Alternatively, assuming our results represent the effect of IGF‐II on disease, they are in agreement with previous findings with respect to PSA‐detected prostate cancer, although they found no evidence for an association of this biomarker with cancer grade.4, 5. Here, IGF2 is linked to cancer.